| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99499 |
|
4,744 |
4,467 |
$326K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,472 |
7,417 |
$275K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,746 |
5,030 |
$257K |
| 87428 |
|
2,384 |
2,204 |
$130K |
| 99050 |
|
4,028 |
3,718 |
$68K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
767 |
763 |
$57K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
642 |
608 |
$46K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,387 |
2,237 |
$31K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,766 |
1,235 |
$31K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
359 |
356 |
$26K |
| 99349 |
|
400 |
336 |
$14K |
| 99348 |
|
457 |
380 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
297 |
278 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
410 |
194 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
92 |
87 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
53 |
49 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
501 |
473 |
$4K |
| 90461 |
|
713 |
580 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
131 |
123 |
$2K |
| G0402 |
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment |
93 |
92 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
46 |
46 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14 |
14 |
$1K |
| 96160 |
|
500 |
494 |
$1K |
| 99345 |
Prolong home eval add 15m |
16 |
15 |
$858.28 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
147 |
136 |
$628.54 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
42 |
39 |
$473.52 |
| 99307 |
|
57 |
25 |
$377.70 |
| 99490 |
Ccm add 20min |
12 |
12 |
$101.92 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
11,377 |
9,209 |
$4.27 |
| 3078F |
|
7,369 |
6,395 |
$0.01 |
| 1159F |
|
9,623 |
7,755 |
$0.01 |
| 1160F |
|
9,611 |
7,745 |
$0.01 |
| 90670 |
|
66 |
66 |
$0.01 |
| 3074F |
|
7,420 |
6,434 |
$0.01 |
| 1126F |
|
42 |
41 |
$0.01 |
| 4019F |
|
167 |
160 |
$0.00 |
| 99072 |
|
400 |
361 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
64 |
64 |
$0.00 |
| 90700 |
|
38 |
38 |
$0.00 |
| 90710 |
|
14 |
14 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
418 |
407 |
$0.00 |
| 3079F |
|
122 |
112 |
$0.00 |
| 3008F |
|
563 |
549 |
$0.00 |
| 90686 |
|
271 |
271 |
$0.00 |
| G9716 |
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason |
64 |
64 |
$0.00 |
| 1111F |
|
28 |
25 |
$0.00 |
| 3044F |
|
76 |
76 |
$0.00 |
| 3048F |
|
13 |
13 |
$0.00 |
| 90651 |
|
29 |
29 |
$0.00 |
| 3075F |
|
66 |
58 |
$0.00 |